Annual report
4021.TEDINET S100OIHF
Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥209.1bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥206.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥204.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥193.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥51.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥42.5bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥43.9bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥40.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥39.1bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥36.2bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥54.2bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥45.5bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥33.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥30.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥29.4bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥27.1bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥39.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥33.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥279.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥265.5bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥249.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥247.0bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥246.0bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥71.7bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥64.9bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥208.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥200.6bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥185.5bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥182.1bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥176.4bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥34.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.4bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥36.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥37.7bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥39.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥37.7bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥22.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥20.3bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥231.73 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥210.09 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥197.67 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.3 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,454.01 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,384.13 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,264.23 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,220.35 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,168.07 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.0% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 19.2% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.5% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.6% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,737 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 2,688 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 2,640 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 2,583 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 2,511 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥170.0bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥162.5bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥160.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥156.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥147.3bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥42.5bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥37.3bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥46.5bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥39.3bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥37.5bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥36.2bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥32.9bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥46.6bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥40.9bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥34.4bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥30.7bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥29.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥28.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥25.4bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥231.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥225.6bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥213.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥210.1bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥208.7bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥62.7bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥59.9bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥168.4bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥165.6bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥155.4bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥151.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥147.2bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥24.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥26.7bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥241.21 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥212.52 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.76 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥188.13 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥169 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥122 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥104 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥82 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥68 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,188.84 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,152.93 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,068.43 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,027.04 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥984.94 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 72.9% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.2% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.6% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.1% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.9% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 143,000,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 145,000,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 146,000,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 149,000,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 151,000,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,929 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 1,924 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 1,890 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 1,861 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 1,819 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 122
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2021-04-01 → 2022-03-31 | ¥614m |
| Otherother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥299m |
| Otherother segments | employees | at 2022-03-31 | 422 pure |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥23.6bn |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥10.9bn |
| Otherother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥12.7bn |
| Otherother segments | segment assets | at 2022-03-31 | ¥12.2bn |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥692m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥127m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥233m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥87.8bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2022-03-31 | −¥22.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥65.0bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥49.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥3.4bn |
| Agrochemicalsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Agrochemicalsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| Agrochemicalsreportable segment | employees | at 2022-03-31 | 517 pure |
| Agrochemicalsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥65.8bn |
| Agrochemicalsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥58.0bn |
| Agrochemicalsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥7.9bn |
| Agrochemicalsreportable segment | segment assets | at 2022-03-31 | ¥90.7bn |
| Agrochemicalsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥18.3bn |
| Chemicalsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Chemicalsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.5bn |
| Chemicalsreportable segment | employees | at 2022-03-31 | 379 pure |
| Chemicalsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥37.6bn |
| Chemicalsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥26.0bn |
| Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥11.6bn |
| Chemicalsreportable segment | segment assets | at 2022-03-31 | ¥32.1bn |
| Chemicalsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| Performance Materialsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥5.7bn |
| Performance Materialsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥3.9bn |
| Performance Materialsreportable segment | employees | at 2022-03-31 | 789 pure |
| Performance Materialsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥81.7bn |
| Performance Materialsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥69.7bn |
| Performance Materialsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥12.0bn |
| Performance Materialsreportable segment | segment assets | at 2022-03-31 | ¥55.1bn |
| Performance Materialsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥27.7bn |
| Pharmaceuticalsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥651m |
| Pharmaceuticalsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥541m |
| Pharmaceuticalsreportable segment | employees | at 2022-03-31 | 174 pure |
| Pharmaceuticalsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥6.6bn |
| Pharmaceuticalsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥6.6bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥49m |
| Pharmaceuticalsreportable segment | segment assets | at 2022-03-31 | ¥9.2bn |
| Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥947m |
| Tradingreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥20m |
| Tradingreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥73m |
| Tradingreportable segment | employees | at 2022-03-31 | 179 pure |
| Tradingreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥80.4bn |
| Tradingreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥59.6bn |
| Tradingreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥20.8bn |
| Tradingreportable segment | segment assets | at 2022-03-31 | ¥31.5bn |
| Tradingreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥10.8bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥9.9bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥295.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥230.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥65.0bn |
| —segment total | segment assets | at 2022-03-31 | ¥230.7bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥54.4bn |
| Otherother segments | capex | 2020-04-01 → 2021-03-31 | ¥388m |
| Otherother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥311m |
| Otherother segments | revenue | 2020-04-01 → 2021-03-31 | ¥23.8bn |
| Otherother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥9.7bn |
| Otherother segments | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥14.1bn |
| Otherother segments | segment assets | at 2021-03-31 | ¥12.8bn |
| Otherother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥831m |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥296m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥191m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥58.5bn |
| Reconciling Itemsreconciling | revenue external | 2020-04-01 → 2021-03-31 | ¥12m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥58.5bn |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥52.3bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥3.3bn |
| Agrochemicalsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥6.4bn |
| Agrochemicalsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2.5bn |
| Agrochemicalsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥63.8bn |
| Agrochemicalsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥57.5bn |
| Agrochemicalsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥6.3bn |
| Agrochemicalsreportable segment | segment assets | at 2021-03-31 | ¥82.8bn |
| Agrochemicalsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥18.2bn |
| Chemicalsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥4.9bn |
| Chemicalsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2.2bn |
| Chemicalsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥31.9bn |
| Chemicalsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥21.9bn |
| Chemicalsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥10.0bn |
| Chemicalsreportable segment | segment assets | at 2021-03-31 | ¥30.8bn |
| Chemicalsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥1.5bn |
| Performance Materialsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3.2bn |
| Performance Materialsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥4.5bn |
| Performance Materialsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥71.6bn |
| Performance Materialsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥62.6bn |
| Performance Materialsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥9.0bn |
| Performance Materialsreportable segment | segment assets | at 2021-03-31 | ¥51.0bn |
| Performance Materialsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥22.4bn |
| Pharmaceuticalsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥475m |
| Pharmaceuticalsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥517m |
| Pharmaceuticalsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥6.7bn |
| Pharmaceuticalsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥6.6bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥43m |
| Pharmaceuticalsreportable segment | segment assets | at 2021-03-31 | ¥9.6bn |
| Pharmaceuticalsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥357m |
| Tradingreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥137m |
| Tradingreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥80m |
| Tradingreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥69.8bn |
| Tradingreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥50.8bn |
| Tradingreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥19.0bn |
| Tradingreportable segment | segment assets | at 2021-03-31 | ¥26.2bn |
| Tradingreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.5bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥15.5bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥10.2bn |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥267.6bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥209.1bn |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥58.5bn |
| —segment total | segment assets | at 2021-03-31 | ¥213.2bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥45.8bn |
| Agrochemicalsreportable segment | employees | at 2022-03-31 | 512 pure |
| Chemicalsreportable segment | employees | at 2022-03-31 | 379 pure |
| Performance Materialsreportable segment | employees | at 2022-03-31 | 587 pure |
| Pharmaceuticalsreportable segment | employees | at 2022-03-31 | 174 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,872
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 225557000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 231022000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 984.94 | |
| Net assets per share (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 1027.04 | |
| Net assets per share (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 1068.43 | |
| Net assets per share (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 1152.93 | |
| Net assets per share (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 1188.84 | |
| Dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 68.00 | |
| Dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 82.00 | |
| Dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 90.00 | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 104.00 | |
| Dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 122.00 | |
| Interim dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 32.00 | |
| Interim dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 40.00 | |
| Interim dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 42.00 | |
| Interim dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 46.00 | |
| Interim dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 50.00 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 169.00 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 188.13 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 201.76 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 212.52 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 241.21 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 0.705 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 0.722 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 0.729 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.734 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.729 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.179 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.187 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.192 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.191 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.206 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 26.15 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 26.95 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 19.53 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 27.81 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 29.97 | |
| Payout ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.402 | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.436 | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.446 | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.489 | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.506 | |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 1819 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 1861 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 1890 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |